Now showing items 11-20 of 53
Instructions for Authors
(Kluwer Academic Publishers; Springer Science+Business Media, 2002-11)
Acceptability of Diagnostic Tests for Breast Cancer
(Kluwer Academic Publishers; Springer Science+Business Media, 2003-05)
Purpose . To assess the acceptability of new non-invasive breast cancer diagnostic tests intended to triage women in need of biopsy.
Consensus statement: Expedition Inspiration 2004 Breast Cancer Symposium ‘Breast Cancer – the Development and Validation of New Therapeutics’
(Kluwer Academic Publishers; Springer, 2005-03)
Evaluation of Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
(Kluwer Academic Publishers; Springer Science+Business Media, 2004-01)
The epidermal growth factor system is a well characterized growth factor receptor pathway, the deregulation of which has been be associated with neoplastic growth. Overexpression or amplification of the epidermal growth ...
Ototoxicity of cisplatin plus standard radiation therapy vs. accelerated radiation therapy in glioblastoma patients
(Kluwer Academic Publishers-Plenum Publishers; Springer Science + Business Media, 2005-11-05)
Purpose : To assess the effect of cisplatin (CDDP) plus concurrent radiation therapy on hearing loss. Methods : 451 patients with glioblastoma multiforme (GBM) were randomly assigned after surgery to: Arm A: Carmustine ...
Non-steroidal anti-inflammatory drug (NSAID) use and levels of a lipid oxidation marker in plasma and nipple aspirate fluids
(Kluwer Academic Publishers-Plenum Publishers; Springer Science+Business Media, Inc., 2006-05)
Non-steroidal anti-inflammatory drugs (NSAIDs) are thought to reduce cancer risk by inhibiting cyclo-oxygenases, resulting in deceased formation of inflammatory mediators and oxidative stress. We examined whether the level ...
Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer
(Kluwer Academic Publishers-Plenum Publishers; Springer Science+Business Media, Inc., 2006-02)
Inflammatory breast cancer (IBC) is the most aggressive form of locally advanced breast cancer (LABC). The IBC phenotype is characterized by an infiltrative growth pattern, increased (lymph)angiogenesis and the propensity ...